AZN INVESTOR NOTICE: Robbins Geller Rudman and Dowd LLP are informing AstraZeneca PLC investors who have suffered substantial losses that they may have the chance to lead a class action lawsuit.

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of AstraZeneca PLC (NASDAQ: AZN) publicly traded securities between February 23, 2022 and December 17, 2024, both dates…

Read More: https://www.businesswire.com/news/home/20250106282322/en/